What is Royalty Pharma's jnj‑4804 — unfunded commitments?

Royalty Pharma (RPRX) reported jnj‑4804 — unfunded commitments of $500.00M in Q1 2026.

What does jnj‑4804 — unfunded commitments mean?

The remaining amount of committed capital that the company has yet to pay out for the JNJ-4804 asset.

Products & Services · Unfunded Commitments

JNJ‑4804 — Unfunded Commitments

Analysis

StatementSegment

CategoryLiquidity

SignalLower is better

VolatilityModerate

First reportedQ1 2026

Last reportedQ1 2026

Rolls up toUnfunded Commitments

How to read this metric

A decrease reflects the fulfillment of investment obligations, while an increase suggests new contractual commitments or delayed funding milestones.

Detailed definition

This metric measures the portion of the total contractual commitment for the JNJ-4804 asset that has not yet been paid o...

Peer comparison

Comparable to unfunded capital commitments or remaining investment obligations found in private equity, venture capital, or specialty finance portfolios.

Metric ID: rprx_segment_jnj_4804_unfunded_commitments

Historical Data

1 periods

	Q1 '26
Value	$500.00M

Similar Metrics at Other Companies

Martin Marietta MaterialsMLM View metric

Ares Management CorporationARES View metric

Raymond James FinancialRJF View metric

KKR & Co.KKR View metric

Johnson & JohnsonJNJ View metric

Natera, Inc.NTRA View metric

Frequently Asked Questions

What is Royalty Pharma's jnj‑4804 — unfunded commitments?: Royalty Pharma (RPRX) reported jnj‑4804 — unfunded commitments of $500.00M in Q1 2026.
What does jnj‑4804 — unfunded commitments mean?: The remaining amount of committed capital that the company has yet to pay out for the JNJ-4804 asset.